Psychological intervention has been shown to reduce the postembolization pain during hepatic arterial chemoembolization therapy.
Psychological intervention has been shown to reduce the postembolization pain during hepatic arterial chemoembolizatiom therapy. It is highly recommended as a complementary approach to pharmacological analgesia according to research published in the issue of the World Journal of Gastroenterology.
Unbearable pain is the most common complaint during and after transarterial embolization. Large doses of opioid analgesics are often required in most patients when the pain is too severe to endure. Because these medications have side effects and a few patients are not susceptive to sedative and analgesic medication, it would be useful to develop nonpharmacologic analgesia approaches to improving this painful experience.In the study it was demonstrated that the psychological status of hepatic malignancy patient was abnormal and several symptoms were related to the pain intensity during the procedure. It was indication to psychological intervention.
When psychological intervention was performed initially, only some of patients described pain relief. Once the medication was administrated, the pain intensity decreased clearly. Therefore, psychological intervention cannot be practiced as the only form of pain relief. However, because the pain management of patients who received psychological intervention & medication was obviously better than that of control group, the effect of psychological intervention cannot be neglected.
"This study is a step forward in pain management of transarterial embolization therapy," says Dr. Wang, "Though it was not a large study with complex trials, it conclusively shows that psychological intervention is effective and provides clinicians a safe, inexpensive, and effective complementary approach to pharmacological analgesia.
After several years of study, it's wonderful to demonstrate that the nonpharmacologic analgesia effectively improves the patient's experience of pain during the transarterial embolization. It is good news for patients."
Source-Eurekalert
SRM/K
